Search
ansuvimab-zykl (Ebanga)
Indications:
- treatment of Zaire Ebolavirus
Dosage:
400 mg injection
Adverse effects:
- most common:
- fever, tachycardia, diarrhea, vomiting, hypotension, tachypnea (these are also common symptoms of Ebolavirus infection)
Mechanism of action:
- binds to a region of the Ebola virus envelope glycoprotein that binds to its human receptor NPC1
Interactions
drug adverse effects of pharmaceutical monoclonal antibodies
General
antiviral agent
pharmaceutical monoclonal antibody
References
- Wilipedia: Ansuvimab
https://en.wikipedia.org/wiki/Ansuvimab
- FDA Drug Safety & Availability. Dec 21, 2020
FDA Approves Treatment for Ebola Virus
https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-treatment-ebola-virus